don't know if this is widely known - see Dr K's 2013 in review...

don't know if this is widely known - see Dr K's 2013 in review on the Novogen site. I think it's compelling reading. Apologies if you've seen it already.
2014 is full of promise. Dr K is realistic in his assessments of how long things might take and to me (a non medico) what he says makes seems to sense.
I like his swipe at analysts - easy to trumpet something in ph 3 when the potential has been absorbed into the SP.
That's why I like these little biotechs. Understanding the story at an early stage puts you way ahead of most. I'm not saying I totally understand nrt, but I'm getting there. I don't expect sp miracles, but all it's going to take is someone with some deep pockets who likes the story and wants in. If what's in the 2013 in Review becomes known widely, there should be interest.
good luck to all in 2014